ticlopidine has been researched along with Thalassemia in 1 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Thalassemia: A group of hereditary hemolytic anemias in which there is decreased synthesis of one or more hemoglobin polypeptide chains. There are several genetic types with clinical pictures ranging from barely detectable hematologic abnormality to severe and fatal anemia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ticlopidine treatment did not significantly improve platelet life-span or factor VIII levels, though it was associated with reduced values of beta TG and PF4." | 2.65 | A double-blind trial of ticlopidine in sickle cell disease. ( Al-Hasani, SF; Kioy, P; Savidge, GF; Semple, MJ, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Semple, MJ | 1 |
| Al-Hasani, SF | 1 |
| Kioy, P | 1 |
| Savidge, GF | 1 |
1 trial available for ticlopidine and Thalassemia
| Article | Year |
|---|---|
A double-blind trial of ticlopidine in sickle cell disease.
Topics: Adult; Anemia, Sickle Cell; Anticoagulants; Blood Coagulation Factors; Blood Platelets; Cell Surviva | 1984 |